ETP-46321
CAS: 1252594-99-2
Ref. 3D-CAC59499
| 1mg | 338.00 € | ||
| 5mg | 483.00 € | ||
| 10mg | 737.00 € | ||
| 25mg | 1,300.00 € | ||
| 50mg | 2,079.00 € |
Product Information
ETP-46321 is an imidazopyrazine that inhibits the activity of the enzyme phosphatase 2A, which is involved in a number of signaling pathways. It has been shown to activate IL-17a, and inhibit tumor growth in mice. ETP-46321 also has pharmacokinetic properties that are suited for oral administration. The drug binds to the catalytic subunit of protein phosphatase 2A (PP2Ac) and prevents it from dephosphorylating its substrate, thereby inhibiting its enzymatic activity. This inhibition leads to increased levels of activated PP2Ac, which in turn leads to the activation and proliferation of cells. ETP-46321 has shown efficacy against cancer cells in vitro and can be used as an immunosuppressant for autoimmune diseases due to its ability to inhibit IL-17a production by T cells.
Chemical properties
Technical inquiry about: 3D-CAC59499 ETP-46321
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
